1. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
    Lei Ding et al, 2019, Cells CrossRef
  2. Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus
    Olorunseun O. Ogunwobi et al, 2019, Frontiers in Oncology CrossRef
  3. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals
    Seung Wan Son et al, 2020, Molecules CrossRef
  4. MicroRNA Expression Profiles and Breast Cancer Chemotherapy
    Matthew G. Davey et al, 2021, International Journal of Molecular Sciences CrossRef
  5. Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
    Shivam Singh et al, 2023, Frontiers in Oncology CrossRef
  6. LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma
    Yuan Li et al, 2020, Cancers CrossRef
  7. The Preventive Effects of Naringin and Naringenin against Paclitaxel-Induced Nephrotoxicity and Cardiotoxicity in Male Wistar Rats
    Shimaa S. Khaled et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  8. New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
    Yeqin Fu et al, 2023, Frontiers in Molecular Biosciences CrossRef
  9. LncRNA OR3A4 Regulated the Growth of Osteosarcoma Cells by Modulating the miR-1207-5p/G6PD Signaling


    Xiaole Wang et al, 2020, OncoTargets and Therapy CrossRef
  10. Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment
    Meng-Yuan Li et al, 2019, Frontiers in Oncology CrossRef
  11. Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
    Nina Petrović et al, 2021, Journal of Mammary Gland Biology and Neoplasia CrossRef
  12. Tanshinol inhibits growth of malignant melanoma cells via regulating miR-1207-5p/CHPF pathway
    Yujie Wang et al, 2020, Archives of Dermatological Research CrossRef
  13. Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin—Low Triple Negative Breast Cancer Cells
    Fayola Levine et al, 2021, Cancers CrossRef
  14. Contribution of miRNAs in the Pathogenesis of Breast Cancer
    Soudeh Ghafouri-Fard et al, 2021, Frontiers in Oncology CrossRef
  15. Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
    Paola Ferrari et al, 2022, International Journal of Molecular Sciences CrossRef